Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices 20209 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

[CDC–2014–0006, Docket Number NIOSH– 

273] 

Notice of Draft Document for Public 

Comment 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of draft document for 

public comment. 

SUMMARY: The National Institute for 

Occupational Safety and Health of the 

Centers for Disease Control and 

Prevention announces the availability of 

a draft method to be published in the 

NIOSH Manual of Analytical Methods 

(NMAM) entitled ‘‘Method 8324: 3- 

Bromopropionic acid in urine; A 

metabolite of 1-bromopropane’’ now 

available for public comment. To view 

the notice and related materials, visit 

http://www.regulations.gov and enter 

CDC–2014–0006 in the search field and 

click ‘‘Search.’’ 

Public comment period: Comments 

must be received June 10, 2014. 

ADDRESSES: You may submit comments, 

identified by CDC–2014–0006 and 

Docket Number NIOSH–273, by either 

of the following two methods: 

• Federal eRulemaking Portal: 

https://www.regulations.gov Follow the 

instructions for submitting comments. 

• Mail: NIOSH Docket Office, Robert 

A. Taft Laboratories, 4676 Columbia 

Parkway, MS C–34, Cincinnati, Ohio 

45226. 

Instructions: All information received 

in response to this notice must include 

the agency name and docket number 

[CDC–2014–0006; NIOSH–273]. All 

relevant comments received will be 

posted without change http://

www.regulations.gov, including any 

personal information provided. All 

information received in response to this 

notice will also be available for public 

examination and copying at the NIOSH 

Docket Office, 4676 Columbia Parkway, 

Room 109, Cincinnati, OH 45226. 

SUPPLEMENTARY INFORMATION: 

Background: The NIOSH Manual of 

Analytical Methods (NMAM) was first 

published in 1974 and currently 

contains over 300 methods that can be 

used by the occupational safety and 

health community to measure worker 

exposures. 1-Bromopropane is an 

industrial solvent often used as a 

substitute for a number of 

chlorofluorocarbon solvents which were 

withdrawn from use because of their 

possible damaging effects to the ozone 

layer. 3-Bromopropionic acid is a 

human metabolite of 1-bromopropane 

and a proposed biomarker of exposure. 

An accurate and precise method was 

developed for the detection and 

quantitation of 3-bromopropionic acid 

in human urine. This method was 

published in the literature (B’Hymer CB, 

Cheever KL [2004]. J Chromatogr B 

802:361–366). The method was 

validated by a second laboratory and is 

proposed for inclusion in NMAM’s 5th 

Edition. 

FOR FURTHER INFORMATION CONTACT: Dale 

Shoemaker, Ph.D., NIOSH DART, 4676 

Columbia Parkway MS R–7, Cincinnati, 

OH 45226. (513) 841–4523. 

Dated: April 7, 2014. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–08141 Filed 4–10–14; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Statistics 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), National 

Center for Health Statistics (NCHS) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 11:00 a.m.–5:30 p.m., 

May 12, 2014, 8:30 a.m.–1:00 p.m., May 13, 

2014 

Place: NCHS Headquarters, 3311 Toledo 

Road, Hyattsville, Maryland 20782. 

Status: This meeting is open to the public; 

however, visitors must be processed in 

accordance with established federal policies 

and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please 

contact Gwen Mustaf, 301–458–4500, glm4@

cdc.gov, or Virginia Cain, vcain@cdc.gov at 

least 10 days in advance for requirements). 

All visitors are required to present a valid 

form of picture identification issued by a 

state, federal or international government. As 

required by the Federal Property 

Management Regulations, Title 41, Code of 

Federal Regulation, Subpart 101–20.301, all 

persons entering in or on Federal controlled 

property and their packages, briefcases, and 

other containers in their immediate 

possession are subject to being x-rayed and 

inspected. Federal law prohibits the knowing 

possession or the causing to be present of 

firearms, explosives and other dangerous 

weapons and illegal substances. The meeting 

room accommodates approximately 100 

people. 

Purpose: This committee is charged with 

providing advice and making 

recommendations to the Secretary, 

Department of Health and Human Services; 

the Director, CDC; and the Director, NCHS, 

regarding the scientific and technical 

program goals and objectives, strategies, and 

priorities of NCHS. 

Matters For Discussion: The agenda will 

include welcome remarks by the Director, 

NCHS; the March 4–5, 2014 Office of 

Analysis and Epidemiology Program Review; 

report from the February 10–11, 2014 

National Academy of Sciences Workshop on 

Guidelines for Returning Individual Results 

from Genome Research Using PopulationBased Specimens; program updates. 

Requests to make oral presentations should 

be submitted in writing to the contact person 

listed below. All requests must contain the 

name, address, telephone number, and 

organizational affiliation of the presenter. 

Written comments should not exceed five 

single-spaced typed pages in length and must 

be received by April 25, 2014. 

The agenda items are subject to change as 

priorities dictate. 

Contact Person For More Information: 

Virginia S. Cain, Ph.D., Director of 

Extramural Research, NCHS/CDC, 3311 

Toledo Road, Room 7208, Hyattsville, 

Maryland 20782, telephone (301) 458–4500, 

fax (301) 458–4020. The Director, 

Management Analysis and Services Office, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities for both the 

Centers for Disease Control and the Agency 

for Toxic Substances and Disease Registry. 

Gary J. Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–08199 Filed 4–10–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–37, CMS–64, 

CMS–10320, CMS–10396, CMS–102 and 

CMS–105, and CMS–367] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 


tkelley on DSK3SPTVN1PROD with NOTICES
20210 Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by May 12, 2014. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 or Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Quarterly 

Statement of Budget for Medical 

Assistance; Use: We require that each 

State Medicaid agency quarterly submit 

the Form CMS–37 via the web-based 

Medicaid and State Children’s Health 

Insurance Program Budget and 

Expenditure System (MBES/CBES). Due 

dates are November 15, February 15, 

May 15 and August 15 of each fiscal 

year. The addendum provides a 

description of forms contained in this 

package. All submissions represent 

equally important components of the 

grant award cycle, but the May and 

November submissions are particularly 

significant for budget formulation. The 

November submission introduces a new 

fiscal year to the budget cycle and 

serves as the basis for the formulation of 

the Medicaid portion of the President’s 

Budget, which is presented to Congress 

in January. The February and August 

submissions are used primarily for 

budget execution in providing interim 

updates to our Office of Financial 

Management, the Department of Health 

and Human Services, the Office of 

Management and Budget and Congress 

depending on the scheduling of the 

national budget review process in a 

given fiscal year. These submissions 

provide us with base information 

necessary to track current year 

obligations and expenditures in relation 

to the current year appropriation and to 

notify senior managers of any 

impending surpluses or deficits. Form 

Number: CMS–37 (OCN: 0938–0101); 

Frequency: Quarterly; Affected Public: 

State, Local, or Tribal Governments; 

Number of Respondents: 56; Total 

Annual Responses: 224; Total Annual 

Hours: 7,616. (For policy questions 

regarding this collection contact 

Abraham John at 410–786–4519). 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Quarterly 

Statement of Expenditure for Medical 

Assistance; Use: Section 1903 of the 

Social Security Act provides the 

authority for collecting this information. 

States are required to submit the form 

CMS–64 quarterly to us no later than 30 

days after the end of the quarter being 

reported. These submissions provide us 

with the information necessary to issue 

the quarterly grant awards, monitor 

current year expenditure levels, 

determine the allowability of State 

claims for reimbursement, develop 

Medicaid financial management 

information provide for State reporting 

of waiver expenditures, ensure that the 

federally-established limit is not 

exceeded for HCBS waivers, and to 

allow for the implementation of the 

Assignment of Rights and Part A and 

Part B Premium (i.e., accounting for 

overdue Part A and Part B Premiums 

under State buy-in agreements)—Billing 

Offsets. Form Number: CMS–64 (OCN: 

0938–0067); Frequency: Quarterly; 

Affected Public: State, Local, or Tribal 

Governments; Number of Respondents: 

56; Total Annual Responses: 224; Total 

Annual Hours: 16,464. (For policy 

questions regarding this collection 

contact Abraham John at 410–786– 

4519). 

3. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title: Health Care 

Reform Insurance Web Portal 

Requirements; Use: This information 

collection is mandated by Sections 1103 

and 10102 of the Patient Protection and 

Affordability Care Act, Public Law 111– 

148 (ACA). Once all of the information 

is collected from insurance issuers of 

major medical health insurance (hereon 

referred to as issuers) and other affected 

parties, it will be displayed at http://

www.healthcare.gov. Issuers are 

required to provide information 

quarterly, and healthcare.gov will be 

updated on a periodic schedule during 

each quarter. The information provided 

will help the general public make 

educated decisions about organizations 

providing private health care insurance. 

We are currently updating a system 

(hereon referred to as web portal) where 

state Departments of Insurance and 

issuers may log in using a custom user 

ID and password validation. The states 

may be asked to provide information on 

issuers in their state and various Web 

sites maintained for consumers. The 

issuers will be tasked with providing 

information on their major medical 

insurance products and plans. They will 

ultimately be given the choice to 

download a basic information template 

to enter data then upload into the web 

portal; to manually enter data within the 

web portal itself; or to submit .xml files 

containing their information. Once the 

states and issuers submit their data, they 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 70 / Friday, April 11, 2014 / Notices 20211 

will receive an email notifying them of 

any errors, and that their submission 

was received. We are both mandating 

the issuers verify and update their 

information on a quarterly basis and 

requesting that States verify Statesubmitted information on an annual 

basis. In the event that an issuer 

enhances its existing plans, proposes 

new plans, or deactivates plans, the 

organization would be required to 

update the information in the web 

portal. Changes occurring during the 

three month quarterly periods will be 

allowed utilizing effective dates for both 

the plans and rates associated with the 

plans. Form Number: CMS–10320 

(OCN: 0938–1086); Frequency: 

Annually, Quarterly; Affected Public: 

Private sector—Business or other forprofits; Number of Respondents: 801; 

Total Annual Responses: 3,051; Total 

Annual Hours: 27,833. (For policy 

questions regarding this collection 

contact Kim Heckstall at 410–786– 

1647.) 

4. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Medication 

Therapy Management Program 

Improvements; Use: Information 

collected by Part D medication therapy 

management programs (as required by 

the standardized format for the 

comprehensive medication review 

summary) will be used by beneficiaries 

or their authorized representatives, 

caregivers, and their healthcare 

providers to improve medication use 

and achieve better healthcare outcomes. 

Subsequent to the publication of the 60- 

day Federal Register notice (January 17, 

2014; 79 FR 3207) non-substantive 

changes have been made to the 

information collection request. Form 

Number: CMS–10396 (OCN: 0938– 

1154); Frequency: Occasionally; 

Affected Public: Private sector (Business 

or other for-profits); Number of 

Respondents: 682; Total Annual 

Responses: 280,352; Total Annual 

Hours: 186,901. (For policy questions 

regarding this collection contact Gary 

Wirth at 410–786–3977). 

5. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Clinical 

Laboratory Improvement Amendments 

of 1988 (CLIA) Budget Workload 

Reports and Supporting Regulations; 

Use: We will use the collected 

information to determine the amount of 

Federal reimbursement for surveys 

conducted. Use of the information 

includes program evaluation, audit, 

budget formulation and budget 

approval. Form CMS–102 is a multipurpose form designed to capture and 

record all budget and expenditure data. 

Form CMS–105 captures the annual 

projected CLIA workload that the State 

survey agency will accomplish. Our 

regional offices also use the information 

to approve the annual projected CLIA 

workload. The information is required 

as part of the section 1864 agreement 

with the state. Form Numbers: CMS–102 

and CMS–105 (OCN: 0938–0599); 

Frequency: Quarterly; Affected Public: 

State, Local, or Tribal Governments; 

Number of Respondents: 50; Total 

Annual Responses: 50; Total Annual 

Hours: 4,500. (For policy questions 

regarding this collection contact Angela 

Stancel at 410–786–4876.) 

6. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicaid Drug 

Program—Monthly and Quarterly Drug 

Reporting Format; Use: Labelers must 

transmit drug data to us within 30 days 

after the end of each calendar month 

and quarter. We calculate the unit rebate 

amount (URA) for each National Drug 

Code and distributes to all state 

Medicaid agencies. States use the URA 

to invoice the labeler for rebates. The 

monthly data is used to calculate 

Federal Upper Limit prices for 

applicable drugs and for states that opt 

to use this data to establish their 

pharmacy reimbursement methodology. 

Form Number: CMS–367 (OCN: 0938– 

0578); Frequency: Monthly and 

quarterly; Affected Public: Private 

sector—Business or other for-profits; 

Number of Respondents: 610; Total 

Annual Responses: 9,760; Total Annual 

Hours: 144,448. (For policy questions 

regarding this collection contact 

Samone Angel at 410–786–1123.) 

Dated: April 8, 2014. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2014–08208 Filed 4–10–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10463 and 

CMS–10521] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

any of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

June 10, 2014. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number (OCN). To be 

assured consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number ___, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/

PaperworkReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 


tkelley on DSK3SPTVN1PROD with NOTICES